AI English summary of an SEC filing — figures as filed
Willis Towers Watson WTWWillis Towers Watson said 2024 revenue was $9.9 billion, compared to $9.5 billion in the prior year, an increase of $447 million, or 5%. Organic revenue growth, adjusting for the impact of foreign currency and acquisitions and disposals, was 5%. Currency translation decreased revenue by $19 million.
Key points
AI summaryWillis Towers Watson said 2024 revenue was $9.9 billion, compared to $9.5 billion in the prior year, an increase of $447 million, or 5%. Organic revenue growth, adjusting for the impact of foreign currency and acquisitions and disposals, was 5%. Currency translation decreased revenue by $19 million.
The company said it recognized a non-cash goodwill impairment charge of $1.0 billion to the BDA reporting unit in connection with the sale of TRANZACT completed on December 31, 2024. Following the impairment, goodwill in the BDA reporting unit was approximately $1.2 billion.
Willis Towers Watson said HWC segment revenue for 2024 was $5.8 billion and segment operating income was $1.7 billion. R&B segment revenue was $4.0 billion and segment operating income was $958 million, compared to $813 million in the prior year. R&B segment operating income increased from the prior year.
The company said it concluded its 3-year Transformation program in Q4 2024, which incurred cumulative costs of $1.115 billion and capital expenditures of $130 million, for a total investment of $1.245 billion. It said it expects additional cash outflows in 2025 from the settlement of accrued costs.
Key figures
Fiscal year ended December 31, 2024
- Revenue
- $9.7B
- Operating income
- $627M
- Net income
- −$98M
- EPS
- −$0.96
- Operating cash flow
- $1.5B
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
2024 Revenue $9.9 billion, Up 5% on As-Reported Basis
Willis Towers Watson said 2024 revenue was $9.9 billion, compared to $9.5 billion in the prior year, an increase of $447 million, or 5%. Organic revenue growth, adjusting for the impact of foreign currency and acquisitions and disposals, was 5%. Currency translation decreased revenue by $19 million.
Source · Based on the MD&A text of the filing
$1.0 billion Goodwill Impairment Related to TRANZACT Sale
The company said it recognized a non-cash goodwill impairment charge of $1.0 billion to the BDA reporting unit in connection with the sale of TRANZACT completed on December 31, 2024. Following the impairment, goodwill in the BDA reporting unit was approximately $1.2 billion.
Source · Based on the MD&A text of the filing
Segment Revenue and Operating Income
Willis Towers Watson said HWC segment revenue for 2024 was $5.8 billion and segment operating income was $1.7 billion. R&B segment revenue was $4.0 billion and segment operating income was $958 million, compared to $813 million in the prior year. R&B segment operating income increased from the prior year.
Source · Based on the MD&A text of the filing
Transformation Program Concluded With Cumulative Costs
The company said it concluded its 3-year Transformation program in Q4 2024, which incurred cumulative costs of $1.115 billion and capital expenditures of $130 million, for a total investment of $1.245 billion. It said it expects additional cash outflows in 2025 from the settlement of accrued costs.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…